Article Information
History
- January 19, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hui Xu1,4,
- Shi-Jun Xu1,4,
- Shu-Juan Xie1,2,
- Yin Zhang1,3,
- Jian-Hua Yang1,
- Wei-Qi Zhang1,
- Man-Ni Zheng1,
- Hui Zhou1 and
- Liang-Hu Qu1,*
- 1Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, P. R. China.
- 2Shujuan Xie’s present address is: Vaccine Research Institute of Sun Yat-sen University, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, P. R. China.
- 3Yin Zhang’s present address is: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Research Center of Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, P. R. China.
- ↵* Correspondence should be addressed to L.Q. (lssqlh{at}mail.sysu.edu.cn).
↵4 These authors contributed equally to this work.
Posted January 19, 2018.
MicroRNA-122 supports robust innate immunity in hepatocytes by suppressing STAT3 phosphorylation
